Foa_Content_of_CDC-RFA-OE20-20010101SUPP21.pdf

Centers for Disease Control and Prevention

Center for Surveillance, Epidemiology, and Laboratory Services

Enhancing Public Health Laboratory Capabilities and Increasing Capacity

CDC-RFA-OE20-20010101SUPP21

02/15/2021

Table of Contents Section I. Funding Opportunity Description

Section II. Award Information

Section III. Eligibility Information

Section IV. Application and Submission Information

Section V. Application Review Information

Section VI. Award Administration Information

Section VII. Agency Contacts

Section VIII. Other Information

Part 1. Overview Information Federal Agency Name:

Federal Centers for Disease Control and Prevention (CDC) Notice of Funding Opportunity (NOFO) Title:

Enhancing Public Health Laboratory Capabilities and Increasing Capacity Announcement Type:

Revision - Type 3 - (Competitive supplement) Additional funds requested to expand the scope of work have elapsed.

Agency Notice of Funding Opportunity Number:

CDC-RFA-OE20-20010101SUPP21

Assistance Listings (CFDA) Number:

93.322 Key Dates:

Due Date for Applications 02/15/2021

02/15/2021 Application must be successfully submitted to Grants.gov by 11:59 pm Eastern Standard Time on the deadline date.

Additional Overview Content:

Executive Summary This notice of funding opportunity announces the availability of emergency supplemental funding to support the Association of Public Health Laboratories (APHL) continued efforts to enhance capabilities and increase capacity of Public Health Laboratories (PHLs). This APHL will do by strengthening the effectiveness and functionality of PHLs, individually and as components of the national laboratory system, to improve public health and prevent, prepare for, and respond to COVID-19 threats. In 2020, APHL was the recipient of a single source umbrella cooperative agreement (CoAg) to strengthen the capacity of PHLs. APHL is therefore uniquely qualified to implement the activities of this supplemental CoAg during this national emergency.

Measurable outcomes of the program will be in alignment with one (or more) of the following performance goal(s) for the CSELS:

The attached project proposals identify the measurable outcomes. APHL will work their designated technical monitors to finalize the projects' outcome measures.

Please note: APHL is expected to collaborate with their CDC point of contact and/or technical monitor on each project to develop realistic process measures. In response to this proposal, APHL should provide a detailed work plan with: outcomes, outcome measures, strategies/activities, and process measures.

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf.

Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html (See section 45 CFR 46.102(d)).

Measurable outcomes of the program will be in alignment with one (or more) of the following performance goal(s) for the Center for Surveillance, Epidemiology, and Laboratory Services

GPRA goal(s)

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.govregs.com/regulations/title42_chapterI_part2_subpartD_section2.52. Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html (See section 45 CFR 46.102(d)).

Section I. Funding Opportunity Description Statutory Authority Under section 317(k)(2) of the Public Health Service Act [42 USC 247b(k)(2), as amended] and the Paycheck Protection Program and Healthcare Enhancement Act, 2020 (P.L. 116-139).

Background On January 20, 2020, CDC activated its Emergency Operations Center. On January 31, 2020, the International Health Regulations Emergency Committee of the World Health Organization declared the emerging outbreak of coronavirus a "public health emergency of international concern" (PHEIC). On February 11, 2020, the World Health Organization announced an official name for the disease that is causing the outbreak of coronavirus disease: COVID-19.

On Friday, March 6, the President signed the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2002. The supplemental contains more than $8 billion, of which $950 million is specifically directed for grants or cooperative agreements to include:

states, localities, territories, etc. to carry out surveillance, epidemiology, laboratory capacity, https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html%20(See%20section%2045%20CFR%2046.102(d)) https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html%20(See%20section%2045%20CFR%2046.102(d)) https://www.govregs.com/regulations/title42_chapterI_part2_subpartD_section2.52 https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html infection control, mitigation, communications, and other preparedness and response activities.

Consistent with the supplemental appropriation, funds were to be allocated, in part, to support public health laboratories within the United States and its territories. The Centers for Disease Control and Prevention (CDC) is taking a multipronged approach to provide at least $10 million in COVID-19 funding to public health laboratories (PHLs). CDC's approach aims to get public health resources out quickly during the COVID-19 declared emergency and enable broad access and opportunity to COVID-19 resources.

State, local, and territorial PHLs play an indispensable role in protecting the health of Americans from new, emerging, and existing health threats by conducting laboratory testing and providing other science-based services. The work of PHL systems is interdigitated with other aspects of public health work, including epidemiology. Public health professionals and policy makers use actionable information from PHLs daily to identify and prioritize these population health threats, and to develop and implement effective interventions. In order to fulfill their critical public health mission, PHLs must be capable of and effective at detecting and responding to myriad of threats across a broad and expanding spectrum of health domains, including infectious diseases, such as COVID-19.

Consistent with the supplemental appropriation, this NOFO aims to support efforts that will enhance the capabilities and increase the capacities of PHLs by: 1) promoting national, state, and local PHL systems that collaborate with clinical laboratories; 2) promoting and supporting health systems-oriented laboratory informatics and information sharing practices; 3) using new data exchange technologies and standards-based interoperability; 4) conducting preparedness assessments and facilitating evaluations of new technologies and methods; 5) analyzing biosafety and biosecurity guidelines and regulations and developing best practices and polices to enhance biosafety and biosecurity in PHLs; and 6) developing resources and providing technical assistance to state and local PHLs to ensure capability and capacity to respond to all public health threats.

Purpose The purpose of this NOFO is to announce the availability of emergency supplemental funding to enable APHL to provide resources and technical assistance to enhance the infrastructure, and strengthen the capacity and capabilities of the nation's public health laboratories to adequately respond to the demands of COVID-19 testing, quality and safety, reporting data management, surveillance, and epidemiology.

Program Implementation Recipient Activities For recipient activities, please refer to the attached project proposals.

In a cooperative agreement, CDC staff is substantially involved in the program activities, above and beyond routine grant monitoring.

CDC Activities

CDC staff will collaborate or participate in project or program activities. For example, the assigned CDC technical monitors in collaboration with other subject matter experts across the agency will do the following:

Work with the recipient and provide technical expertise in support of project activities in each focus area

Meet with the recipient's public health staff at least monthly and on ad hoc basis via conference calls to discuss emerging issues, project progress, and future actions

Provide access to technical guidance and training that will strengthen staff capacity relevant to implementation of all required activities of the program

Provide technical guidance to recipient to improve the quality and effectiveness of work plans, evaluation strategies, products and services. For example, collaborate in assessing measurable progress towards meeting program outcomes, establishing measurement, and accountability systems for documenting outcomes, such as increased performance improvements and best or promising practice

Foster communication, coordination, and collaboration between CDC, PHLs, partners, and other stakeholders of public health system

Work with recipient to identify and address challenges that may impeded the success of the project

Provide financial monitoring and negotiations to ensure proposed activities and resource allocations are in alignment with CDC's priorities, as well as guidance on budget submission template

Facilitate national coordination of activities Ensure that established quality standards are met for training, guidance, and technical tools Develop compatible platforms that align with established PHLs systems and protocols Develop mechanisms for documenting and sharing lessons learned Collaborate in analyzing data and information collected, and in preparing written summaries and manuscripts for peer-reviewed and non-peer reviewed publications and presentations, with CDC co-authorship, where appropriate

Provide guidance and input on branding (i.e., co-branding and logo licensing) of products, services, communications materials, websites or other digital platform (e.g., social media, mobile apps), or any other resource in which CDC is engaged in with recipient as part of this cooperative agreement.

Provide technical assistance to ensure products that are a direct result of this NOFO are made available in the public domain, for example: collaborate to compile and publish accomplishments, best practices, and lessons learned during the project period (possibly through conferences, guidance and material development, webinars, data sharing publications, electronic social media, participation in meetings, committee, conference calls and work groups).

Section II. Award Information Type of Award:

CA (Cooperative Agreement) CDC substantial involvement in this program appears in the Activities Section above.

Award Mechanism:

U60 Cooperative Agreements in Occupational Safety and Heath Research, Demonstrations, U60 Evaluation, and Education

Fiscal Year Funds:

Approximate Total Supplemental Funding:

$ 3,000,000 Approximate Number of Awards:

Approximate Average Award:

$ 25,000,000 This amount is for the budget period only and includes direct costs and indirect costs as applicable.

Floor of Individual Award Range:

$ 2,000,000 Ceiling of Individual Award Range:

$ 3,000,000 This ceiling is for a 12-month budget period.

Anticipated Award Date:

March 16, 2021

Budget Period Length:

12 month(s)

Period of Performance Length:

1 year(s)

Section III. Eligibility Information Eligible Applicants The following recipients may submit an application:

Eligibility Category:

25 (Others (see text field entitled "Additional Information on Eligibility" for clarification))

Additional Information on Eligibility This supplemental funding opportunity announcement is a single-source eligibility. The only applicant eligible to apply is the Association for Public Health Laboratories (APHL) because of the specialized skills and abilities to enhance the capacity of public health laboratories (PHLs).

Required Registrations System for Award Management and Universal Identifier Requirements An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System: All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements. The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or Internet at http://fedgov.dnb.com/webform/displayHomePage.do. The DUNS number will be provided at no charge. If funds are awarded to an applicant organization that includes sub-recipients, those sub-recipients must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM): The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as a recipient. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC. If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process usually requires not more than five business days, and registration must be renewed annually.

Additional information about registration procedures may be found at https://www.sam.gov/SAM/.

c. Grants.gov: The first step in submitting an application online is registering your organization through www.grants.gov, the official HHS E-grant website. Registration information is located at the "Applicant Registration" option at www.grants.gov. All applicant organizations must register with www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants must start the registration process as early as possible.

Cost Sharing or Matching Cost Sharing / Matching Requirement:

No Although cost sharing or matching is not required, leveraging existing or other resources is encouraged.

Other Special Requirements Note: Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting a grant, loan, or an award.

Maintenance of Effort Maintenance of Effort is not required for this program https://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do https://www.sam.gov/SAM/ https://www.grants.gov/ http://www.grants.gov/ https://www.grants.gov/

Section IV. Application and Submission Information Address to Request Application Package Applicants must download the application package associated with this funding opportunity from Grants.gov.

If the applicant encounters technical difficulties with Grants.gov, the applicant should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week, with the exception of all Federal Holidays. The Contact Center provides customer service to the applicant community. The extended hours will provide applicants support around the clock, ensuring the best possible customer service is received any time it is needed. You can reach the Grants.gov Support Center at 1-800-518-4726 or by email at support@grants.gov. Submissions sent by email, fax, CD’s or thumb drives of applications will not be accepted.

Content and Form of Application Submission Unless specifically indicated, this announcement requires submission of the following information:

This is a supplemental to the original Notice of Funding Opportunity (CDC-RFA-OE20-2001).

Project Abstract A Project Abstract must be completed in the Grants.gov application forms. The Project Abstract must contain a summary of the proposed activity suitable for dissemination to the public. It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed. It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically literate lay reader. This abstract must not include any proprietary/confidential information.

Project Narrative A Project Narrative must be submitted with the application forms. The project narrative must be uploaded in a PDF file format when submitting via Grants.gov. The narrative must be submitted in the following format:

The narrative should address activities to be conducted over the entire Period of Performance and must include the following items in the order listed.

Additional information may be included in the application appendices. The appendices must be uploaded to the "Other Attachments Form" of application package in Grants.gov. Note:

appendices will not be counted toward the narrative page limit. This additional information includes:

Additional information submitted via Grants.gov must be uploaded in a PDF file format, and should be named:

No more than 30 electronic attachments should be uploaded per application.

mailto:support@grants.gov

CDC Assurances and Certifications: All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://wwwn.cdc.gov/grantassurances/ (S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx.

Applicants may follow either of the following processes:

Complete the applicable assurances and certifications with each application submission, name the file “Assurances and Certifications” and upload it as a PDF file with at www.grants.gov

Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

Risk Assessment Questionnaire Requirement

CDC is required to conduct pre-award risk assessments to determine the risk an applicant poses to meeting federal programmatic and administrative requirements by taking into account issues such as financial instability, insufficient management systems, non-compliance with award conditions, the charging of unallowable costs, and inexperience. The risk assessment will include an evaluation of the applicant’s CDC Risk Questionnaire, located at https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, as well as a review of the applicant’s history in all available systems; including OMB-designated repositories of government-wide eligibility and financial integrity systems (see 45 CFR 75.205(a)), and other sources of historical information. These systems include, but are not limited to: FAPIIS (https://www.fapiis.gov/), including past performance on federal contracts as per Duncan Hunter National Defense Authorization Act of 2009; Do Not Pay list; and System for Award Management (SAM) exclusions.

CDC requires all applicants to complete the Risk Questionnaire, OMB Control Number 0920- 1132 annually. This questionnaire, which is located at https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, along with supporting documentation must be submitted with your application by the closing date of the Notice of Funding Opportunity Announcement. If your organization has completed CDC’s Risk Questionnaire within the past 12 months of the closing date of this NOFO, then you must submit a copy of that questionnaire, or submit a letter signed by the authorized organization representative to include the original submission date, organization’s EIN and DUNS.

When uploading supporting documentation for the Risk Questionnaire into this application package, clearly label the documents for easy identification of the type of documentation. For example, a copy of Procurement policy submitted in response to the questionnaire may be labeled using the following format: Risk Questionnaire Supporting Documents _ Procurement Policy.

http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx https://www.grants.gov/ http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf

Duplication of Efforts

Applicants are responsible for reporting if this application will result in programmatic, budgetary, or commitment overlap with another application or award (i.e. grant, cooperative agreement, or contract) submitted to another funding source in the same fiscal year. Programmatic overlap occurs when (1) substantially the same project is proposed in more than one application or is submitted to two or more funding sources for review and funding consideration or (2) a specific objective and the project design for accomplishing the objective are the same or closely related in two or more applications or awards, regardless of the funding source. Budgetary overlap occurs when duplicate or equivalent budgetary items (e.g., equipment, salaries) are requested in an application but already are provided by another source. Commitment overlap occurs when an individual’s time commitment exceeds 100 percent, whether or not salary support is requested in the application. Overlap, whether programmatic, budgetary, or commitment of an individual’s effort greater than 100 percent, is not permitted. Any overlap will be resolved by the CDC with the applicant and the PD/PI prior to award.

Report Submission: The applicant must upload the report in Grants.gov under “Other Attachment Forms.” The document should be labeled: "Report on Programmatic, Budgetary, and Commitment Overlap.”

Submission Dates and Times This announcement is the definitive guide on application content, submission, and deadline. It supersedes information provided in the application instructions. If the application submission does not meet the deadline published herein, it will not be eligible for review and the recipient will be notified the application did not meet the submission requirements.

This section provides applicants with submission dates and times. Applications that are submitted after the deadlines will not be processed.

If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Application Deadline Date

Due Date for Applications 02/15/2021

02/15/2021 Explanation of Deadlines: Application must be successfully submitted to Grants.gov by 11:59 pm Eastern Standard Time on the deadline date.

Intergovernmental Review Executive Order 12372 does not apply to this program.

Pilot Program for Enhancement of Employee Whistleblower Protections All applicants will be subject to a term and condition that applies the terms of 48 CFR section

3.908 to the award and requires that recipients inform their employees in writing (in the predominant native language of the workforce) of employee whistleblower rights and protections under 41 U.S.C 4712.

Copyright Interest Provisions This provision is intended to ensure that the public has access to the results and accomplishments of public health activities funded by CDC. Pursuant to applicable grant regulations and CDC’s Public Access Policy, Recipient agrees to submit into the National Institutes of Health (NIH) Manuscript Submission (NIHMS) system an electronic version of the final, peer-reviewed manuscript of any such work developed under this award upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication. Also at the time of submission, Recipient and/or the Recipient’s submitting author must specify the date the final manuscript will be publicly accessible through PubMed Central (PMC). Recipient and/or Recipient’s submitting author must also post the manuscript through PMC within twelve (12) months of the publisher's official date of final publication; however the author is strongly encouraged to make the subject manuscript available as soon as possible. The recipient must obtain prior approval from the CDC for any exception to this provision.

The author's final, peer-reviewed manuscript is defined as the final version accepted for journal publication, and includes all modifications from the publishing peer review process, and all graphics and supplemental material associated with the article. Recipient and its submitting authors working under this award are responsible for ensuring that any publishing or copyright agreements concerning submitted articles reserve adequate right to fully comply with this provision and the license reserved by CDC. The manuscript will be hosted in both PMC and the CDC Stacks institutional repository system. In progress reports for this award, recipient must identify publications subject to the CDC Public Access Policy by using the applicable NIHMS identification number for up to three (3) months after the publication date and the PubMed Central identification number (PMCID) thereafter.

Federal Funding Accountability and Transparency Act of 2006 (FFATA), P.L. 109–282, as amended by section 6202 of P.L. 110–252 requires full disclosure of all entities and organizations receiving Federal funds including awards, contracts, loans, other assistance, and payments through a single publicly accessible Web site, www.USASpending.gov.

Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by applicants: 1) information on executive compensation when not already reported through the SAM, and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000.

For the full text of the requirements under the FFATA and HHS guidelines, go to:

https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf, https://www.fsrs.gov/documents/ffata_legislation_110_252.pdf http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.

Funding Restrictions Funding Restrictions:

Restrictions, which must be taken into account while writing the budget, are as follows:

In accordance with the United States Protecting Life in Global Health Assistance policy, all non-governmental organization (NGO) applicants acknowledge that foreign NGOs that receive funds provided through this award, either as a prime recipient or subrecipient, are strictly prohibited, http://www.usaspending.gov/ https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf, https://www.fsrs.gov/documents/ffata_legislation_110_252.pdf http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.

regardless of the source of funds, from performing abortions as a method of family planning or engaging in any activity that promotes abortion as a method of family planning, or to provide financial support to any other foreign non-governmental organization that conducts such activities. See Additional Requirement (AR) 35 for applicability (https://www.cdc.gov/grants/additionalrequirements/ar-35.html).

Recipients may not use funds for research.

Recipients may not use funds for clinical care.

Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.

Recipients may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.

The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible.

Other than for normal and recognized executive-legislative relationships, no funds may be used for: publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body.

See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on lobbying for CDC recipients.

A recipient of a grant or cooperative agreement awarded by the Department of Health and Human Services (HHS) with funds made available under the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123) agrees to: 1) comply with existing and/or future directives and guidance from the Secretary regarding control of the spread of COVID-19; 2) in consultation and coordination with HHS, provide, commensurate with the condition of the individual, COVID-19 patient care regardless of the individual’s home jurisdiction and/or appropriate public health measures (e.g., social distancing, home isolation);

and 3) assist the United States Government in the implementation and enforcement of federal orders related to quarantine and isolation.

If recipient disburses any funds received pursuant to this award to a local jurisdiction, recipient shall ensure that the local jurisdiction complies with the terms and conditions of this award.

Consistent with the full scope of applicable grant regulations (45 C.F.R. 75.322), the purpose of this award, and the underlying funding, the recipient is expected to provide to CDC copies of and/or access to COVID-19 data collected with these funds.

CDC will specify in further guidance and directives what is encompassed by this requirement.

https://foa.grantsolutions.gov/n%20accordance%20with%20the%20United%20States%20Protecting%20Life%20in%20Global%20Health%20Assistance%20policy,%20all%20non-governmental%20organization%20(NGO)%20applicants%20acknowledge%20that%20foreign%20NGOs%20that%20receive%20funds%20provided%20through%20this%20award,%20either%20as%20a%20prime%20recipient%20or%20subrecipient,%20are%20strictly%20prohibited,%20regardless%20of%20the%20source%20of%20funds,%20from%20performing%20abortions%20as%20a%20method%20of%20family%20planning%20or%20engaging%20in%20any%20activity%20that%20promotes%20abortion%20as%20a%20method%20of%20family%20planning,%20or%20to%20provide%20financial%20support%20to%20any%20other%20foreign%20non-governmental%20organization%20that%20conducts%20such%20activities.%20%20See%20Additional%20Requirement%20(AR)%2035%20for%20applicability%20(https:/www.cdc.gov/grants/additionalrequirements/ar-35.html).

http://www.cdc.gov/grants/additionalrequirements/index.html

This award is contingent upon agreement by the recipient to comply with existing and future guidance from the HHS Secretary regarding control of the spread of COVID-19.

To the extent applicable, Recipient will comply with Section 18115 of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), Public Law 116-136, with respect to the reporting to the Secretary of Health and Human Services of results of tests intended to detect SARS–CoV–2 or to diagnose a possible case of COVID–19.

The recipient can obtain guidance for completing a detailed justified budget on the CDC website, at the following Internet address: http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html

Other Submission Requirements Application Submission Submit the application electronically by using the forms and instructions posted for this funding opportunity on www.Grants.gov.

Note: Application submission is not concluded until successful completion of the validation process. After submission of your application package, recipients will receive a "submission receipt" email generated by Grants.gov. Grants.gov will then generate a second e-mail message to recipients which will either validate or reject their submitted application package.

This validation process may take as long as two (2) business days. Recipients are strongly encouraged check the status of their application to ensure submission of their application package is complete and no submission errors exists. To guarantee that you comply with the application deadline published in the Notice of Funding Opportunity, recipients are also strongly encouraged to allocate additional days prior to the published deadline to file their application. Non-validated applications will not be accepted after the published application deadline date.

In the event that you do not receive a ''validation'' email within two (2) business days of application submission, please contact Grants.gov. Refer to the email message generated at the time of application submission for instructions on how to track your application or the Application User Guide, Version 3.0 page 57.

Electronic Submission of Application:

Applications must be submitted electronically by using the forms and instructions posted for this notice of funding opportunity at www.grants.gov. Applicants can complete the application package using Workspace, which allows forms to be filled out online or offline. All application attachments must be submitted using a PDF file format. Instructions and training for using Workspace can be found at www.grants.gov under the "Workspace Overview" option.

Applications submitted through www.Grants.gov, are electronically time/date stamped and assigned a tracking number. The Authorized Organizational Representative (AOR) will receive an e-mail notice of receipt when HHS/CDC receives the application. The tracking number serves to document submission and initiate the electronic validation process before the application is made available to CDC for processing.

http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html

If the recipient encounters technical difficulties with Grants.gov, the recipient should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week. The Contact Center provides customer service to the recipient community. The extended hours will provide recipients support around the clock, ensuring the best possible customer service is received any time it’s needed. You can reach the Grants.gov Support Center at 1-800- 518-4726 or by email at support@grants.gov. Submissions sent by e-mail, fax, CD’s or thumb drives of applications will not be accepted.

After consulting with the Grants.gov Support Center, if the technical difficulties remain unresolved and electronic submission is not possible to meet the established deadline, organizations may submit a request prior to the application deadline by email to the Grants Management Specialist/Officer for permission to submit a paper application. An organization's request for permission must: (a) include the Grants.gov case number assigned to the inquiry, (b) describe the difficulties that prevent electronic submission and the efforts taken with the Grants.gov Support Center (c) be submitted to the Grants Management Specialist/Officer at least 3 calendar days prior to the application deadline. Paper applications submitted without prior approval will not be considered.

Section V. Application Review Information Criteria Eligible recipients will be evaluated against the following criteria:

Approach Maximum Points: 0 Assess the extent to which the applicant:

1. Described the overall strategy for accomplishing the objectives of the project (15 points)

2. Provided a work plan with strategies, activities, and performance measures that align to specific program outcomes (10 points)

3. Described an organized approach to implementing the strategies and activities listed in the Purpose Section of the NOFO (10 points)

Evaluation and Performance Measurement Maximum Points: 0 Assess the extent to which the applicant:

1. Proposed a high-level evaluation plan or described the approach to evaluate progress in attaining NOFO outcomes (25 points)

Applicant's Organizational Capacity to Implement the Approach Maximum Points: 0

Assess the extent to which the applicant:

1. Indicated expertise, experience, and capacity to efficiently and effectively assess the technical assistance needs of PHLs to respond to this NOFO (10 points)

2. Indicated expertise, experience, and capacity to efficiently and effectively address the technical assistance needs of PHLs to respond to this NOFO (10 points)

3. Demonstrated appropriate existing infrastructure and skill sets to carry-out the proposed strategies and activities of this NOFO (20 points)

Assess the extent to which the applicant:

mailto:support@grants.gov

1. Proposed a budget appropriate for the planned activities

2. Provided a detailed/itemized budget and narrative consistent with the stated strategies, activities, and performance and evaluation measures

3. Provided budget details on proposed contractors/consultants to include work plan, period of performance, and unit cost

Review and Selection Process Review Eligible applications will be jointly reviewed for responsiveness by Center for Surveillance, Epidemiology, and Laboratory Services and PGO. Incomplete applications and applications that are non-responsive will not advance through the review process. Recipients will be notified in writing of the results.

An objective review panel will evaluate complete and responsive applications according to the criteria listed in Section V. Application Review Information, subsection entitled "Criteria".

Selection CDC will provide justification for any decision to fund out of rank order.

Anticipated Announcement and Award Dates Section VI. Award Administration Information Award Notices Successful recipients will receive a Notice of Award (NoA) from the CDC Office of Grants Services. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and e-mailed to the program director. A hard copy of the NoA will be mailed to the recipient fiscal officer identified in the application.

Unsuccessful recipients will receive notification of the results of the application review by mail.

Administrative and National Policy Requirements Administrative and National Policy Requirements, Additional Requirements (ARs) outline the administrative requirements found in 45 CFR Part 75 and the HHS Grants Policy Statement and other requirements as mandated by statute or CDC policy. CDC programs must indicate which ARs are relevant to the NOFO. All NOFOs from the Center for Global Health must include AR-

35. Recipients must then comply with the ARs listed in the NOFO. Do not include any ARs that do not apply to this NOFO. NOFO Recipients must comply with administrative and national policy requirements as appropriate. For more information on the Code of Federal Regulations, visit the National Archives and Records Administration: https://www.archives.gov/federal-register/cfr. For competing supplements, ARs remain in effect as published in the original announcement.

Continuing Continuations - The full text of the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, 45 CFR 75, can be found at:

https://www.ecfr.gov/cgi-bin/text-idx?node=pt45.1.75 https://www.archives.gov/federal-register/cfr https://www.archives.gov/federal-register/cfr https://www.ecfr.gov/cgi-bin/text-idx?node=pt45.1.75

Reporting Federal Funding Accountability and Transparency Act of 2006 (FFATA), P.L. 109–282, as amended by section 6202 of P.L. 110–252 requires full disclosure of all entities and organizations receiving Federal funds including awards, contracts, loans, other assistance, and payments through a single publicly accessible Web site, http://www.USASpending.gov

Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by applicants: 1) information on executive compensation when not already reported through the SAM, and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000.

For the full text of the requirements under the FFATA and HHS guidelines, go to:

https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf, https://www.fsrs.gov /documents /ffata_legislation_ 110_252.pdf http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.

Section VII. Agency Contacts CDC encourages inquiries concerning this announcement.

For programmatic technical assistance and general inquiries, contact:

First Name:

Se'Veda Last Name:

Kent Project Officer Department of Health and Human Services Centers for Disease Control and Prevention

Street 1:

Street 2:

City:

State:

Zip:

Telephone:

770-488-8268 Email:

khx9@cdc.gov For financial, grants management, budget assistance and general inquiries, contact:

Address:

First Name:

Louvern Last Name:

Asante http://www.usaspending.gov/ https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf, https://www.fsrs.gov/documents/ffata_legislation_110_252.pdf http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.

Grants Management Specialist Department of Health and Human Services Office of Grants Services

Street 1:

Street 2:

City:

State:

Zip:

Telephone:

770-488-2835 Email:

lha5@cdc.gov Section VIII. Other Information Other CDC Notice of Funding Opportunities can be found at www.grants.gov.